Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Pharmacotherapy|March 26, 2010
Hospital resource utilization and costs of inappropriate treatment of candidemiaHeather M Arnold, Scott T Micek, Andrew F Shorr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2005
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trialAndrew F Shorr, Neringa Zadeikis, William L Jackson, et al.
Surgical Infections|March 6, 2010
Bacteremia increases the risk of death among patients with soft-tissue infectionsScott T Micek, Alex P Hoban, Victor Pham, et al.
Critical Care (London, England)|October 16, 2021
Timing of antibiotic therapy in the ICUMarin H Kollef, Andrew F Shorr, Matteo Bassetti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2011
Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency departmentAndrew F Shorr, Marya D Zilberberg, Richard Reichley, et al.
Respiratory Medicine|October 8, 2005
Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung diseaseChristopher J Lettieri, Ganesh R Veerappan, Joseph M Parker, et al.
Surgical Infections|May 8, 2014
Macrolides are associated with a better survival rate in patients hospitalized with community-acquired but not healthcare-associated pneumoniaColleen McEvoy, Scott T Micek, Richard M Reichley, et al.
Critical Care (London, England)|July 24, 2014
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusDipen A Patel, Andrew F Shorr, Jean Chastre, et al.
Clinical Therapeutics|July 31, 2017
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive PathogensDavid B Huang, Thomas M File, Antoni Torres, et al.
Critical Care (London, England)|June 20, 2006
Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcomeAndrew F Shorr, Gordon R Bernard, Jean-Francois Dhainaut, et al.
Pageof 26